1970
DOI: 10.1111/j.1432-1033.1970.tb01203.x
|View full text |Cite
|
Sign up to set email alerts
|

The Binding of Americium and Plutonium to Bone Glycoproteins

Abstract: By means of a gel filtration technique it is shown that plutonium and americium differ in their mode of binding to two glycoproteins isolated from bovine cortical bone. Plutonium binds more strongly than americium, plutonium binding is maximal a t pH 6 and americium a t p H 8, and sialic acid is involved in the binding of plutonium but not americium. The mechanisms by which these elements bind to glycoproteins in vitro are discussed.A number of metals are now known to concentrate in bone where they may cause s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1973
1973
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…1 and Table 1). Even though plutonium deposits established in bone tissue are usually considered to be retained tenaciously (Chipperfield and Taylor 1970, 1972) and hence not easily removable by DTPA (Guilmette et al 2003) in humans, James et al observed an ability of multiple DTPA treatments to reduce skeletal plutonium level, predominantly from trabecular bone surfaces (James et al 2007). With regard to the liver, a chelation of hepatic transuranic deposits in animals (Bhattacharyya et al 1978; Grémy et al 2016) and humans (Roedler et al 1989; James et al 2007) has been reported by several authors.…”
Section: Resultsmentioning
confidence: 99%
“…1 and Table 1). Even though plutonium deposits established in bone tissue are usually considered to be retained tenaciously (Chipperfield and Taylor 1970, 1972) and hence not easily removable by DTPA (Guilmette et al 2003) in humans, James et al observed an ability of multiple DTPA treatments to reduce skeletal plutonium level, predominantly from trabecular bone surfaces (James et al 2007). With regard to the liver, a chelation of hepatic transuranic deposits in animals (Bhattacharyya et al 1978; Grémy et al 2016) and humans (Roedler et al 1989; James et al 2007) has been reported by several authors.…”
Section: Resultsmentioning
confidence: 99%
“…It has been suggested that the binding molecules are glycoproteins or proteoglycans, constituents of the osteoid layer of unmineralised new bone on growing surfaces. [43][44][45][46] However, this suggestion is not consistent with the presence of 239Pu and 241 Am on all types of bone surface, including resting and resorbing areas, and the observation that 239PU on growing surfaces is largely concentrated on the surface of the mineralised bone .47 Other studies have implicated phosphoproteins, demonstrating the ability of molecules in mineralising rat dentine to bind lanthanum; 48 binding to phospholipids has also been suggested. 49 Recently, uptake of radium from transferrin and incorporation into ferritin in osteoblasts has been demonstrated.5° Uptake into osteoblasts may also occur for 239Pu and 241 Am with important implications for their potential to induce osteosarcoma.…”
Section: Discussionmentioning
confidence: 98%